Product NDC: | 48818-001 |
Proprietary Name: | Folotyn |
Non Proprietary Name: | pralatrexate |
Active Ingredient(s): | 20 mg/mL & nbsp; pralatrexate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 48818-001 |
Labeler Name: | Allos Therapeutics |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA022468 |
Marketing Category: | NDA |
Start Marketing Date: | 20090924 |
Package NDC: | 48818-001-02 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (48818-001-02) > 2 mL in 1 VIAL, SINGLE-USE |
NDC Code | 48818-001-02 |
Proprietary Name | Folotyn |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (48818-001-02) > 2 mL in 1 VIAL, SINGLE-USE |
Product NDC | 48818-001 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | pralatrexate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20090924 |
Marketing Category Name | NDA |
Labeler Name | Allos Therapeutics |
Substance Name | PRALATREXATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Folate Analog Metabolic Inhibitor [EPC] |